Articles
| Open Access |
DOI: Problems Of Metabolic Syndrome
Maksuda Ahmedjanovna Karimova , Assistant, Department Of Microbiology, Urgench Branch Of Tashkent Medical Academy, Urgench, Republic Of Uzbekistan Dilnoza Kakhramanovna Kurbanbaeva , Assistant, Department Of Microbiology Of Urgench Branch Of Tashkent Medical Academy, Urgench, Republic Of UzbekistanAbstract
At the beginning of the third millennium, for mankind, which overcame the epidemic of life-threatening infections during its centuries-old history, the problem of cardiovascular diseases (CVD) came to the fore in relevance among all causes of morbidity and mortality. A significant role in this was played by lifestyle modification associated with limiting physical activity, increasing the calorie content of food, and a steady increase in emotional stress. All of this potentiates the main risk factors for CVD, which are a “negative asset of progress,” namely increased blood pressure (BP), dyslipidemia, diabetes mellitus (DM) and obesity. Since 1988, after G. Reaven's Banting lecture, it is customary to designate the interconnected combination of these pathologies by the single term "metabolic syndrome X".
Keywords
Metabolic syndrome, arterial hypertension,, adipose tissue, obesity, retinopathy, gout, insulin resistance
References
Giralt M., Villarroya F. White, brown, beige/brite: different adipose cells for different functions. Endocrinology, 2013. 154 (9):2992-3000.doi:10.1210/en. 2013-1403.
Mendez-Senchez N., Charez-Tapia., Motola-Kuba D. «Metabolic sindrome as a risk factor for gallstone disiase» World J. Gastroenterol., 2005. Mar. 11 (11): 1653-1657.
Trevisan M. et al. Syndrome X and mortality: a population-based study. // Pharmacology, 1999. V. 55. P. 244.
Vlachopoulos C., Rokkas K., Ioakeimidis N. et al. Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links // Eur. Urol., 2007. Vol. 52. P. 1590-1600.
Article Statistics
Copyright License
Copyright (c) 2021 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.